|
Sep 1, 2011
By:
Julian Upton
Especially when payers come to the table holding the best cards — leaving industry second-guessing its strategy.
|
May 1, 2011
By:
Julian Upton
The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance
|
|
Will Roche's precedent push the regulatory community to create standards that will level the playing field for all contenders?
Oct 1, 2010
By:
Julian Upton
Will Roche's precedent push the regulatory community to create standards that will level the playing field for all contenders?
|
May 1, 2010
By:
Julian Upton
The three-way race for control of Parliament leaves the future of the British pharmaceutical industry in the balance.
|
Feb 1, 2010
By:
Julian Upton
Last year was a trying one for the UK's National Institute for Health and Clinical Excellence. Will 2010 be any easier
|
Jan 14, 2009
By:
Julian Upton
Long-standing Nycomed CEO Håkan Björklund tells Pharm Exec Europe how the company is looking to new products, and new territories, to combat the patent expiry of its biggest product.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
